{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "c30188aa-33ed-4504-87a6-653e5492e771",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['/opt/homebrew/Cellar/python@3.11/3.11.5/Frameworks/Python.framework/Versions/3.11/lib/python311.zip', '/opt/homebrew/Cellar/python@3.11/3.11.5/Frameworks/Python.framework/Versions/3.11/lib/python3.11', '/opt/homebrew/Cellar/python@3.11/3.11.5/Frameworks/Python.framework/Versions/3.11/lib/python3.11/lib-dynload', '', '/Users/jan535/code/HECTRE/.venv/lib/python3.11/site-packages']\n"
     ]
    }
   ],
   "source": [
    "import sys, os, logging\n",
    "print(sys.path)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "c121dae3-2350-4839-b2eb-63628b56b66a",
   "metadata": {},
   "outputs": [],
   "source": [
    "PROJ_ROOT = os.path.abspath('../..')\n",
    "sys.path.insert(0, os.path.abspath('../..'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "386e3e51-ac6a-4375-a559-73c5e9c2a584",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['/Users/jan535/code/HECTRE', '/opt/homebrew/Cellar/python@3.11/3.11.5/Frameworks/Python.framework/Versions/3.11/lib/python311.zip', '/opt/homebrew/Cellar/python@3.11/3.11.5/Frameworks/Python.framework/Versions/3.11/lib/python3.11', '/opt/homebrew/Cellar/python@3.11/3.11.5/Frameworks/Python.framework/Versions/3.11/lib/python3.11/lib-dynload', '', '/Users/jan535/code/HECTRE/.venv/lib/python3.11/site-packages']\n"
     ]
    }
   ],
   "source": [
    "print(sys.path)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "2966f43e-8f0a-41ab-bca1-66df8511f9e7",
   "metadata": {},
   "outputs": [],
   "source": [
    "%load_ext autoreload\n",
    "%autoreload 2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "de052973-2ada-4306-bef3-e380926e624e",
   "metadata": {},
   "outputs": [],
   "source": [
    "from hectre.metrics import accuracy\n",
    "logging.disable()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "49cf16c6-8ba2-459b-9675-2b84b3f3a3f2",
   "metadata": {},
   "outputs": [],
   "source": [
    "acc = accuracy.cdf_accuracy(\n",
    "    PROJ_ROOT + \"/hectre/tests/test_data/305_deBruin_2018.pdfdata\",\n",
    "    \"EASI-50;EASI-75;EASI-90\",\n",
    "    PROJ_ROOT + \"/hectre/tests/test_data/cdfs/305_deBruin_2018.csv\"\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "b2d83497-f117-43ff-9958-51717f2f82e0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'comparison': {'test_clin_data':                                      ARM.BLIND ARM.RANDFLG    ARM.TRT  \\\n",
      "dupilumab 300 qw          easi50  Double-Blind        TRUE  Dupilumab   \n",
      "                          easi90  Double-Blind        TRUE  Dupilumab   \n",
      "                          easi75  Double-Blind        TRUE  Dupilumab   \n",
      "placebo       placebo     easi50  Double-Blind        TRUE    Placebo   \n",
      "                          easi90  Double-Blind        TRUE    Placebo   \n",
      "                          easi75  Double-Blind        TRUE    Placebo   \n",
      "dupilumab 300 every2weeks easi50  Double-Blind        TRUE  Dupilumab   \n",
      "                          easi90  Double-Blind        TRUE  Dupilumab   \n",
      "                          easi75  Double-Blind        TRUE  Dupilumab   \n",
      "\n",
      "                                         ARM.TRTCLASS ARM.DOSE ARM.DOSEU  \\\n",
      "dupilumab 300 qw          easi50  Monoclonal antibody      300        mg   \n",
      "                          easi90  Monoclonal antibody      300        mg   \n",
      "                          easi75  Monoclonal antibody      300        mg   \n",
      "placebo       placebo     easi50              Placebo                      \n",
      "                          easi90              Placebo                      \n",
      "                          easi75              Placebo                      \n",
      "dupilumab 300 every2weeks easi50  Monoclonal antibody      300        mg   \n",
      "                          easi90  Monoclonal antibody      300        mg   \n",
      "                          easi75  Monoclonal antibody      300        mg   \n",
      "\n",
      "                                     ARM.ROUTE    ARM.REGIMEN ARM.FORMULATION  \\\n",
      "dupilumab 300 qw          easi50  Subcutaneous             qw                   \n",
      "                          easi90  Subcutaneous             qw                   \n",
      "                          easi75  Subcutaneous             qw                   \n",
      "placebo       placebo     easi50  Subcutaneous        Placebo                   \n",
      "                          easi90  Subcutaneous        Placebo                   \n",
      "                          easi75  Subcutaneous        Placebo                   \n",
      "dupilumab 300 every2weeks easi50  Subcutaneous  Every 2 weeks                   \n",
      "                          easi90  Subcutaneous  Every 2 weeks                   \n",
      "                          easi75  Subcutaneous  Every 2 weeks                   \n",
      "\n",
      "                                 N.ARM  ... RSP.UCI PCHBSL.STAT PCHBSL.VAL  \\\n",
      "dupilumab 300 qw          easi50   110  ...                                  \n",
      "                          easi90   110  ...                                  \n",
      "                          easi75   110  ...                                  \n",
      "placebo       placebo     easi50   108  ...                                  \n",
      "                          easi90   108  ...                                  \n",
      "                          easi75   108  ...                                  \n",
      "dupilumab 300 every2weeks easi50   107  ...                                  \n",
      "                          easi90   107  ...                                  \n",
      "                          easi75   107  ...                                  \n",
      "\n",
      "                                 PCHBSL.VAR PCHBSL.VARU PCHBSL.LCI PCHBSL.UCI  \\\n",
      "dupilumab 300 qw          easi50                                                \n",
      "                          easi90                                                \n",
      "                          easi75                                                \n",
      "placebo       placebo     easi50                                                \n",
      "                          easi90                                                \n",
      "                          easi75                                                \n",
      "dupilumab 300 every2weeks easi50                                                \n",
      "                          easi90                                                \n",
      "                          easi75                                                \n",
      "\n",
      "                                 ARM.PCT.MALE ARM.AGE ARM.AGEU  \n",
      "dupilumab 300 qw          easi50         60.0    38.0    years  \n",
      "                          easi90         60.0    38.0    years  \n",
      "                          easi75         60.0    38.0    years  \n",
      "placebo       placebo     easi50         63.0    37.5    years  \n",
      "                          easi90         63.0    37.5    years  \n",
      "                          easi75         63.0    37.5    years  \n",
      "dupilumab 300 every2weeks easi50         60.7    38.0    years  \n",
      "                          easi90         60.7    38.0    years  \n",
      "                          easi75         60.7    38.0    years  \n",
      "\n",
      "[9 rows x 48 columns], 'test_lit_data': AU                  M. de Bruin-Weller;D. Thaçi;C.H. Smith;K. Reic...\n",
      "TI                  Dupilumab with concomitant topical corticoster...\n",
      "JR                                     British Journal of Dermatology\n",
      "PY                                                               2018\n",
      "VL                                                                178\n",
      "IS                                                                  5\n",
      "PG                                                          1083-1101\n",
      "AB                  Background Atopic dermatitis is a chronic infl...\n",
      "SA                                                    LIBERTY AD CAFÉ\n",
      "REGID                                                     NCT02755649\n",
      "STD.IND                                             Atopic dermatitis\n",
      "STD.DESIGN                                                   Parallel\n",
      "STD.GEO.LOCATION                        UK;BE;DE;FR;NL;PL;ES;IT;SE;CH\n",
      "STD.PHASE                                                           3\n",
      "N.STUDY                                                           325\n",
      "Name: 0, dtype: object, 'control_clin_data':                              ARM.BLIND ARM.RANDFLG    ARM.TRT  \\\n",
      "placebo   0   qw  easi50  Double-Blind        True    placebo   \n",
      "dupilumab 300 qw  easi50  Double-Blind        True  dupilumab   \n",
      "              q2w easi50  Double-Blind        True  dupilumab   \n",
      "placebo   0   qw  easi75  Double-Blind        True    placebo   \n",
      "dupilumab 300 qw  easi75  Double-Blind        True  dupilumab   \n",
      "              q2w easi75  Double-Blind        True  dupilumab   \n",
      "placebo   0   qw  easi90  Double-Blind        True    placebo   \n",
      "dupilumab 300 qw  easi90  Double-Blind        True  dupilumab   \n",
      "              q2w easi90  Double-Blind        True  dupilumab   \n",
      "\n",
      "                                             ARM.TRTCLASS ARM.DOSE ARM.DOSEU  \\\n",
      "placebo   0   qw  easi50                          Placebo        0        MG   \n",
      "dupilumab 300 qw  easi50  Interleukin 4R alpha inhibitors      300        MG   \n",
      "              q2w easi50  Interleukin 4R alpha inhibitors      300        MG   \n",
      "placebo   0   qw  easi75                          Placebo        0        MG   \n",
      "dupilumab 300 qw  easi75  Interleukin 4R alpha inhibitors      300        MG   \n",
      "              q2w easi75  Interleukin 4R alpha inhibitors      300        MG   \n",
      "placebo   0   qw  easi90                          Placebo        0        MG   \n",
      "dupilumab 300 qw  easi90  Interleukin 4R alpha inhibitors      300        MG   \n",
      "              q2w easi90  Interleukin 4R alpha inhibitors      300        MG   \n",
      "\n",
      "                         ARM.ROUTE ARM.REGIMEN ARM.FORMULATION N.ARM  ...  \\\n",
      "placebo   0   qw  easi50        SC          QW                   108  ...   \n",
      "dupilumab 300 qw  easi50        SC          QW                   110  ...   \n",
      "              q2w easi50        SC         Q2W                   107  ...   \n",
      "placebo   0   qw  easi75        SC          QW                   108  ...   \n",
      "dupilumab 300 qw  easi75        SC          QW                   110  ...   \n",
      "              q2w easi75        SC         Q2W                   107  ...   \n",
      "placebo   0   qw  easi90        SC          QW                   108  ...   \n",
      "dupilumab 300 qw  easi90        SC          QW                   110  ...   \n",
      "              q2w easi90        SC         Q2W                   107  ...   \n",
      "\n",
      "                         RSP.UCI PCHBSL.STAT PCHBSL.VAL PCHBSL.VAR  \\\n",
      "placebo   0   qw  easi50                                             \n",
      "dupilumab 300 qw  easi50                                             \n",
      "              q2w easi50                                             \n",
      "placebo   0   qw  easi75                                             \n",
      "dupilumab 300 qw  easi75                                             \n",
      "              q2w easi75                                             \n",
      "placebo   0   qw  easi90                                             \n",
      "dupilumab 300 qw  easi90                                             \n",
      "              q2w easi90                                             \n",
      "\n",
      "                         PCHBSL.VARU PCHBSL.LCI PCHBSL.UCI ARM.PCT.MALE  \\\n",
      "placebo   0   qw  easi50                                           63.0   \n",
      "dupilumab 300 qw  easi50                                           60.0   \n",
      "              q2w easi50                                           60.7   \n",
      "placebo   0   qw  easi75                                           63.0   \n",
      "dupilumab 300 qw  easi75                                           60.0   \n",
      "              q2w easi75                                           60.7   \n",
      "placebo   0   qw  easi90                                           63.0   \n",
      "dupilumab 300 qw  easi90                                           60.0   \n",
      "              q2w easi90                                           60.7   \n",
      "\n",
      "                         ARM.AGE ARM.AGEU  \n",
      "placebo   0   qw  easi50    37.5       YR  \n",
      "dupilumab 300 qw  easi50    38.0       YR  \n",
      "              q2w easi50    38.0       YR  \n",
      "placebo   0   qw  easi75    37.5       YR  \n",
      "dupilumab 300 qw  easi75    38.0       YR  \n",
      "              q2w easi75    38.0       YR  \n",
      "placebo   0   qw  easi90    37.5       YR  \n",
      "dupilumab 300 qw  easi90    38.0       YR  \n",
      "              q2w easi90    38.0       YR  \n",
      "\n",
      "[9 rows x 48 columns], 'control_lit_data': AU                  De Bruin-Weller M; Thaci D; Smith CH; Reich K;...\n",
      "TI                  Dupilumab with concomitant topical corticoster...\n",
      "JR                                                      BR.J.DERMATOL\n",
      "PY                                                               2018\n",
      "VL                                                                178\n",
      "IS                                                                  5\n",
      "PG                                                          1083~1101\n",
      "AB                  Background: Atopic dermatitis is a chronic inf...\n",
      "SA                                                    LIBERTY AD CAFE\n",
      "REGID                               NCT02755649;EudraCT2015-002653-35\n",
      "STD.IND                                             Atopic Dermatitis\n",
      "STD.DESIGN                                                   Parallel\n",
      "STD.GEO.LOCATION                        AT;BE;DE;IE;NL;PL;RU;SK;ES;GB\n",
      "STD.PHASE                                                     Phase 3\n",
      "N.STUDY                                                           325\n",
      "Name: 0, dtype: object, 'row_matches_clin':                                                Matched Test Row  Similarity\n",
      "placebo   0   qw  easi50           (placebo, , placebo, easi50)          72\n",
      "dupilumab 300 qw  easi50           (dupilumab, 300, qw, easi50)         100\n",
      "              q2w easi50  (dupilumab, 300, every2weeks, easi50)          80\n",
      "placebo   0   qw  easi75           (placebo, , placebo, easi75)          72\n",
      "dupilumab 300 qw  easi75           (dupilumab, 300, qw, easi75)         100\n",
      "              q2w easi75  (dupilumab, 300, every2weeks, easi75)          80\n",
      "placebo   0   qw  easi90           (placebo, , placebo, easi90)          72\n",
      "dupilumab 300 qw  easi90           (dupilumab, 300, qw, easi90)         100\n",
      "              q2w easi90  (dupilumab, 300, every2weeks, easi90)          80, 'comp_values_clin':                           ARM.BLIND  ARM.RANDFLG  ARM.TRT  ARM.TRTCLASS  \\\n",
      "placebo   0   qw  easi50        100          100      100           100   \n",
      "dupilumab 300 qw  easi50        100          100      100            36   \n",
      "              q2w easi50        100          100      100            36   \n",
      "placebo   0   qw  easi75        100          100      100           100   \n",
      "dupilumab 300 qw  easi75        100          100      100            36   \n",
      "              q2w easi75        100          100      100            36   \n",
      "placebo   0   qw  easi90        100          100      100           100   \n",
      "dupilumab 300 qw  easi90        100          100      100            36   \n",
      "              q2w easi90        100          100      100            36   \n",
      "\n",
      "                          ARM.DOSE  ARM.DOSEU  ARM.ROUTE  ARM.REGIMEN  \\\n",
      "placebo   0   qw  easi50         0          0         29            0   \n",
      "dupilumab 300 qw  easi50       100        100         29          100   \n",
      "              q2w easi50       100        100         29           25   \n",
      "placebo   0   qw  easi75         0          0         29            0   \n",
      "dupilumab 300 qw  easi75       100        100         29          100   \n",
      "              q2w easi75       100        100         29           25   \n",
      "placebo   0   qw  easi90         0          0         29            0   \n",
      "dupilumab 300 qw  easi90       100        100         29          100   \n",
      "              q2w easi90       100        100         29           25   \n",
      "\n",
      "                          ARM.FORMULATION  N.ARM  ...  RSP.UCI  PCHBSL.STAT  \\\n",
      "placebo   0   qw  easi50              100    100  ...      100          100   \n",
      "dupilumab 300 qw  easi50              100    100  ...      100          100   \n",
      "              q2w easi50              100    100  ...      100          100   \n",
      "placebo   0   qw  easi75              100    100  ...      100          100   \n",
      "dupilumab 300 qw  easi75              100    100  ...      100          100   \n",
      "              q2w easi75              100    100  ...      100          100   \n",
      "placebo   0   qw  easi90              100    100  ...      100          100   \n",
      "dupilumab 300 qw  easi90              100    100  ...      100          100   \n",
      "              q2w easi90              100    100  ...      100          100   \n",
      "\n",
      "                          PCHBSL.VAL  PCHBSL.VAR  PCHBSL.VARU  PCHBSL.LCI  \\\n",
      "placebo   0   qw  easi50         100         100          100         100   \n",
      "dupilumab 300 qw  easi50         100         100          100         100   \n",
      "              q2w easi50         100         100          100         100   \n",
      "placebo   0   qw  easi75         100         100          100         100   \n",
      "dupilumab 300 qw  easi75         100         100          100         100   \n",
      "              q2w easi75         100         100          100         100   \n",
      "placebo   0   qw  easi90         100         100          100         100   \n",
      "dupilumab 300 qw  easi90         100         100          100         100   \n",
      "              q2w easi90         100         100          100         100   \n",
      "\n",
      "                          PCHBSL.UCI  ARM.PCT.MALE  ARM.AGE  ARM.AGEU  \n",
      "placebo   0   qw  easi50         100           100      100        57  \n",
      "dupilumab 300 qw  easi50         100           100      100        57  \n",
      "              q2w easi50         100           100      100        57  \n",
      "placebo   0   qw  easi75         100           100      100        57  \n",
      "dupilumab 300 qw  easi75         100           100      100        57  \n",
      "              q2w easi75         100           100      100        57  \n",
      "placebo   0   qw  easi90         100           100      100        57  \n",
      "dupilumab 300 qw  easi90         100           100      100        57  \n",
      "              q2w easi90         100           100      100        57  \n",
      "\n",
      "[9 rows x 48 columns], 'comp_values_lit': AU                   96\n",
      "TI                   95\n",
      "JR                   60\n",
      "PY                  100\n",
      "VL                  100\n",
      "IS                  100\n",
      "PG                  100\n",
      "AB                   89\n",
      "SA                   97\n",
      "REGID                50\n",
      "STD.IND             100\n",
      "STD.DESIGN          100\n",
      "STD.GEO.LOCATION     69\n",
      "STD.PHASE            25\n",
      "N.STUDY             100\n",
      "dtype: Int64, 'row_similarities':                          dupilumab               placebo                \\\n",
      "                               300                                       \n",
      "                                qw               placebo                 \n",
      "                            easi50 easi90 easi75  easi50 easi90 easi75   \n",
      "placebo   0   qw  easi50        72     67     67      72     67     67   \n",
      "dupilumab 300 qw  easi50       100     95     95      50     45     45   \n",
      "              q2w easi50        98     93     93      49     44     44   \n",
      "placebo   0   qw  easi75        67     61     72      67     61     72   \n",
      "dupilumab 300 qw  easi75        95     90    100      45     40     50   \n",
      "              q2w easi75        93     88     98      44     39     49   \n",
      "placebo   0   qw  easi90        67     72     61      67     72     61   \n",
      "dupilumab 300 qw  easi90        95    100     90      45     50     40   \n",
      "              q2w easi90        93     98     88      44     49     39   \n",
      "\n",
      "                           dupilumab                \n",
      "                                 300                \n",
      "                         every2weeks                \n",
      "                              easi50 easi90 easi75  \n",
      "placebo   0   qw  easi50          53     49     49  \n",
      "dupilumab 300 qw  easi50          78     73     73  \n",
      "              q2w easi50          80     76     76  \n",
      "placebo   0   qw  easi75          49     44     53  \n",
      "dupilumab 300 qw  easi75          73     69     78  \n",
      "              q2w easi75          76     72     80  \n",
      "placebo   0   qw  easi90          49     53     44  \n",
      "dupilumab 300 qw  easi90          73     78     69  \n",
      "              q2w easi90          76     80     72  }, 'lit_acc_pct': 85.4, 'num_control_rows': 9, 'matched_control_rows': 9, 'clin_data_col_accs': ARM.BLIND                  100.0\n",
      "ARM.RANDFLG                100.0\n",
      "ARM.TRT                    100.0\n",
      "ARM.TRTCLASS           57.333333\n",
      "ARM.DOSE               66.666667\n",
      "ARM.DOSEU              66.666667\n",
      "ARM.ROUTE                   29.0\n",
      "ARM.REGIMEN            41.666667\n",
      "ARM.FORMULATION            100.0\n",
      "N.ARM                      100.0\n",
      "N.ARM.STATANAL         96.333333\n",
      "N.ARM.EVENT.SUBJ           100.0\n",
      "STATANAL.POP               100.0\n",
      "STATANAL.METHOD        85.333333\n",
      "STATANAL.IMP.METHOD    44.444444\n",
      "ARM.TIME1                  100.0\n",
      "ARM.TIME1U                  57.0\n",
      "ENDPOINT                   100.0\n",
      "BSL.STAT                   100.0\n",
      "BSL.VAL                    100.0\n",
      "BSL.VALU                   100.0\n",
      "BSL.VAR                    100.0\n",
      "BSL.VARU                   100.0\n",
      "BSL.LCI                    100.0\n",
      "BSL.UCI                    100.0\n",
      "CHBSL.STAT                 100.0\n",
      "CHBSL.VAL                  100.0\n",
      "CHBSL.VALU                 100.0\n",
      "CHBSL.VAR                  100.0\n",
      "CHBSL.VARU                 100.0\n",
      "CHBSL.LCI                  100.0\n",
      "CHBSL.UCI                  100.0\n",
      "RSP.STAT                     0.0\n",
      "RSP.VAL                    100.0\n",
      "RSP.VALU               88.888889\n",
      "RSP.VAR                    100.0\n",
      "RSP.VARU               66.666667\n",
      "RSP.LCI                    100.0\n",
      "RSP.UCI                    100.0\n",
      "PCHBSL.STAT                100.0\n",
      "PCHBSL.VAL                 100.0\n",
      "PCHBSL.VAR                 100.0\n",
      "PCHBSL.VARU                100.0\n",
      "PCHBSL.LCI                 100.0\n",
      "PCHBSL.UCI                 100.0\n",
      "ARM.PCT.MALE               100.0\n",
      "ARM.AGE                    100.0\n",
      "ARM.AGEU                    57.0\n",
      "dtype: Float64}\n"
     ]
    }
   ],
   "source": [
    "print(acc)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "aca317d1-09a3-4aa0-bb2d-56844d6abd6e",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
